Common doses are 2 to 5 milligrams per week, split into 2 or 3 shots, for 4 to 8 weeks
Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients
Purity, dosing, long-term outcomes, and safety are not well established in human trials
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
NAE reports associated with GLP-1 RAs were extracted, and disproportionality analysis was performed to identify NAEs significantly disproportionately related to these agents, which were defined as GLP-1 RA-related NAEs in this work